Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting

INTRODUCTION: Randomized trials indicate that adjuvant radiotherapy plus tamoxifen decrease the five-year risk of recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery from about 20% to 8%. The aims of this study were to examine the use and impact of these therapi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Habel, Laurel A, Achacoso, Ninah S, Haque, Reina, Nekhlyudov, Larissa, Fletcher, Suzanne W, Schnitt, Stuart J, Collins, Laura C, Geiger, Ann M, Puligandla, Balaram, Acton, Luana, Quesenberry, Charles P
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2009
Matèries:
Research article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815548/
https://ncbi.nlm.nih.gov/pubmed/19922614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2453
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars